Clinical observation and analysis of heparin calcium as a precaution against kidney involvements in Henoch Schonlein purpura patients
Abstract：Objective To explore the effectivity and feasibility of heparincalcium as a precaution against kidney involvements in Henoch-Schonlein purpura patients. Methods The 59 HSP patients were divided into the heparin calcium treated group and the control group at random. β2-M and Alb of urine were monitored constantly. Results No significant differences were found between the two groups in β2-M and Alb of urine before treatment ( P＞0. 05 ). The two indexes of the heparin calcium treated group were lower than that of the control group after 3 and 6 months' treatment,and significant differences could be observed( P ＜ 0.01 ). As to Alb of urine, there were no significant differences between the heparin calciunm treated group and the non-HSP group after 6 months' treatment( P＞0.05 ). Conclusions Heparin calcium can be used to protect against kidney involvements in HSP patients safely.
Machine-generated Keywords：
Publication Date：2001-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：2( 205 )